Robert Burns
Stock Analyst at H.C. Wainwright
(4.88)
# 316
Out of 4,575 analysts
1040
Total ratings
50.3%
Success rate
24.4%
Average return
Main Sectors:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics | Reiterated: Buy | $27 → $21 | $4.12 | +409.71% | 8 | Jul 20, 2026 | |
| PRLD Prelude Therapeutics | Reiterated: Buy | $8 | $3.83 | +108.88% | 24 | Jul 15, 2026 | |
| NRIX Nurix Therapeutics | Reiterated: Buy | $32 → $34 | $23.38 | +45.42% | 31 | Jul 10, 2026 | |
| FATE Fate Therapeutics | Reiterated: Buy | $7 | $2.41 | +190.46% | 23 | Jul 9, 2026 | |
| ELVN Enliven Therapeutics | Reiterated: Buy | $56 → $65 | $52.95 | +22.76% | 12 | Jul 9, 2026 | |
| RVMD Revolution Medicines | Reiterated: Buy | $195 | $189.23 | +3.05% | 46 | Jul 6, 2026 | |
| MOLN Molecular Partners AG | Reiterated: Buy | $13 | $3.89 | +234.19% | 7 | Jul 6, 2026 | |
| EXEL Exelixis | Reiterated: Buy | $56 | $55.37 | +1.14% | 25 | Jul 2, 2026 | |
| ORIC ORIC Pharmaceuticals | Reiterated: Buy | $25 | $12.10 | +106.61% | 48 | Jun 24, 2026 | |
| CGEM Cullinan Therapeutics | Reiterated: Buy | $30 | $17.10 | +75.44% | 10 | Jun 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $46 | $22.86 | +101.22% | 43 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $3.00 | +666.67% | 15 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.41 | +75.44% | 10 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $39.76 | +38.33% | 27 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.57 | +600.64% | 30 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $66 | $26.63 | +147.84% | 22 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.15 | - | 45 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $16 | $3.55 | +350.70% | 1 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $33 → $35 | $23.89 | +46.50% | 3 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $2.91 | +346.74% | 10 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8269 | - | 13 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 | $27.02 | +55.44% | 14 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $3.83 | +82.77% | 4 | May 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $28 | $18.44 | +51.84% | 35 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $6.42 | +164.80% | 32 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.76 | +525.00% | 41 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $20 | $8.52 | +134.74% | 15 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $31.73 | +38.67% | 17 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.70 | - | 34 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $8.82 | +228.80% | 7 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $130 | $89.33 | +45.53% | 104 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.71 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $11 | $1.74 | +532.18% | 32 | Apr 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $9.70 | - | 44 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $27 | $7.79 | +246.60% | 4 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.45 | +451.72% | 12 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $2.11 | +373.93% | 7 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $1.24 | +303.23% | 21 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $7.90 | - | 29 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $18.21 | n/a | 8 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0008 | n/a | 6 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3243 | n/a | 19 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $20 | $0.10 | n/a | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.216 | n/a | 13 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $34.90 | n/a | 18 | Mar 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $5.59 | n/a | 7 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $3.24 | n/a | 15 | May 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.60 | n/a | 16 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.29 | n/a | 8 | Mar 5, 2021 |
OnKure Therapeutics
Jul 20, 2026
Reiterated: Buy
Price Target: $27 → $21
Current: $4.12
Upside: +409.71%
Prelude Therapeutics
Jul 15, 2026
Reiterated: Buy
Price Target: $8
Current: $3.83
Upside: +108.88%
Nurix Therapeutics
Jul 10, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $23.38
Upside: +45.42%
Fate Therapeutics
Jul 9, 2026
Reiterated: Buy
Price Target: $7
Current: $2.41
Upside: +190.46%
Enliven Therapeutics
Jul 9, 2026
Reiterated: Buy
Price Target: $56 → $65
Current: $52.95
Upside: +22.76%
Revolution Medicines
Jul 6, 2026
Reiterated: Buy
Price Target: $195
Current: $189.23
Upside: +3.05%
Molecular Partners AG
Jul 6, 2026
Reiterated: Buy
Price Target: $13
Current: $3.89
Upside: +234.19%
Exelixis
Jul 2, 2026
Reiterated: Buy
Price Target: $56
Current: $55.37
Upside: +1.14%
ORIC Pharmaceuticals
Jun 24, 2026
Reiterated: Buy
Price Target: $25
Current: $12.10
Upside: +106.61%
Cullinan Therapeutics
Jun 24, 2026
Reiterated: Buy
Price Target: $30
Current: $17.10
Upside: +75.44%
Jun 22, 2026
Reiterated: Buy
Price Target: $46
Current: $22.86
Upside: +101.22%
Jun 22, 2026
Reiterated: Buy
Price Target: $23
Current: $3.00
Upside: +666.67%
Jun 18, 2026
Reiterated: Buy
Price Target: $13
Current: $7.41
Upside: +75.44%
Jun 18, 2026
Reiterated: Buy
Price Target: $55
Current: $39.76
Upside: +38.33%
Jun 16, 2026
Reiterated: Buy
Price Target: $11
Current: $1.57
Upside: +600.64%
Jun 10, 2026
Reiterated: Buy
Price Target: $27 → $66
Current: $26.63
Upside: +147.84%
Jun 8, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.15
Upside: -
Jun 4, 2026
Initiated Coverage: Buy
Price Target: $16
Current: $3.55
Upside: +350.70%
Jun 3, 2026
Rated: Buy
Price Target: $33 → $35
Current: $23.89
Upside: +46.50%
Jun 1, 2026
Reiterated: Buy
Price Target: $13
Current: $2.91
Upside: +346.74%
Jun 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.8269
Upside: -
Jun 1, 2026
Reiterated: Buy
Price Target: $42
Current: $27.02
Upside: +55.44%
May 28, 2026
Reiterated: Buy
Price Target: $7
Current: $3.83
Upside: +82.77%
May 26, 2026
Reiterated: Buy
Price Target: $25 → $28
Current: $18.44
Upside: +51.84%
May 26, 2026
Reiterated: Buy
Price Target: $17
Current: $6.42
Upside: +164.80%
May 22, 2026
Reiterated: Buy
Price Target: $11
Current: $1.76
Upside: +525.00%
May 22, 2026
Reiterated: Buy
Price Target: $15 → $20
Current: $8.52
Upside: +134.74%
May 12, 2026
Reiterated: Buy
Price Target: $44
Current: $31.73
Upside: +38.67%
May 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.70
Upside: -
May 1, 2026
Reiterated: Buy
Price Target: $29
Current: $8.82
Upside: +228.80%
Apr 27, 2026
Reiterated: Buy
Price Target: $130
Current: $89.33
Upside: +45.53%
Apr 21, 2026
Reiterated: Hold
Price Target: n/a
Current: $3.71
Upside: -
Apr 16, 2026
Reiterated: Buy
Price Target: $8 → $11
Current: $1.74
Upside: +532.18%
Apr 13, 2026
Downgraded: Sell
Price Target: n/a
Current: $9.70
Upside: -
Mar 23, 2026
Reiterated: Buy
Price Target: $50 → $27
Current: $7.79
Upside: +246.60%
Feb 13, 2026
Maintained: Buy
Price Target: $8
Current: $1.45
Upside: +451.72%
Feb 3, 2026
Reiterated: Buy
Price Target: $10
Current: $2.11
Upside: +373.93%
Nov 12, 2025
Reiterated: Buy
Price Target: $5
Current: $1.24
Upside: +303.23%
Aug 19, 2025
Reiterated: Hold
Price Target: n/a
Current: $7.90
Upside: -
Sep 3, 2024
Rated: Hold
Price Target: n/a
Current: $18.21
Upside: n/a
Jul 16, 2024
Rated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a
May 24, 2024
Rated: Hold
Price Target: n/a
Current: $0.3243
Upside: n/a
Mar 21, 2024
Reiterated: Buy
Price Target: $110 → $20
Current: $0.10
Upside: n/a
Jan 8, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.216
Upside: n/a
Mar 21, 2023
Reiterated: Hold
Price Target: n/a
Current: $34.90
Upside: n/a
Mar 17, 2023
Reiterated: Buy
Price Target: $22
Current: $5.59
Upside: n/a
May 10, 2022
Reiterated: Buy
Price Target: $11
Current: $3.24
Upside: n/a
Oct 22, 2021
Maintained: Sell
Price Target: n/a
Current: $1.60
Upside: n/a
Mar 5, 2021
Reiterated: Buy
Price Target: $10
Current: $1.29
Upside: n/a